Clostridium difficile infection history and symptoms

Jump to navigation Jump to search

Clostridium difficile Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Clostridium difficile from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Abdominal X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Clostridium difficile infection history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Clostridium difficile infection history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Clostridium difficile infection history and symptoms

CDC on Clostridium difficile infection history and symptoms

Clostridium difficile infection history and symptoms in the news

Blogs on Clostridium difficile infection history and symptoms

Directions to Hospitals Treating Clostridium difficile

Risk calculators and risk factors for Clostridium difficile infection history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Often clinicians begin treatment before results have come back based on clinical presentation to prevent complications. Knowledge of the local epidemiology of intestinal flora of a particular institution can guide therapy.

In adults, a clinical prediction rule found the best signs are[1] :

  • significant diarrhea ("new onset of > 3 partially formed or watery stools per 24 hour period")
  • exposure of antibiotics
  • abdominal pain
  • foul stool odor

The presence of any one of these findings has a sensitivity of 86% and a specificity of 45%.[1] In this study of hospitalized patients with a prevalence of positive cytotoxin assays of 14%, the positive predictive value was 20% and the negative predictive value was 95%.

History and Symptoms

Clinical manifestations can be quite variable. Some patients are asymptomatic, and others can present critically ill with toxic megacolon.

  • Up to 2/3 of infected hospitalized patients are asymptomatic, but shed organisms and contaminate their environment. These patients are called C. Diff fecal excretors. These patients can be treated with vancomycin or metronidazole, but the bug is often not eradicated in these patients.
  • The reason for the variability is not clear and is not accounted for by strain differences. Host factors are probably important, such as the presence of antitoxin antibodies and colonic toxin receptors.
  • Risk factors for severe colitis include malignancy, Chronic Obstructive Pulmonary Disease (COPD), immunosuppression, renal failure, exposure to anti-peristaltic meds and clindamycin.
  • Onset is usually during or shortly after a course of antibiotics. Cases rarely occur even a month after a course of antibiotics. Rarely patients have no recent history of antibiotics.

Antibiotic-associated diarrhea with C. diff infection, but without colitis may present as:

Antibiotic-associated diarrhea with C. diff infection with colitis but without pseudomembrane development may present as:

Antibiotic-associated diarrhea with C. diff infection with colitis and pseudomembrane development presents with prominent signs and symptoms as described above and sometimes:

Fulminant colitis is an uncommon complication that occurs in 2-3% of patients with C. Diff, and can results in perforation, prolonged ileus, megacolon, and death. Patients may present with:

Toxic megacolon is an enlarged, dilated colon >7cm associated severe systemic toxicity. It may also present with:

  • Small intestinal dilation
  • Air-fluid levels
  • Submucosal edema resulting in thumb-printing

References

  1. 1.0 1.1 Katz DA, Lynch ME, Littenberg B (1996). "Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea". Am. J. Med. 100 (5): 487–95. doi:10.1016/S0002-9343(95)00016-X. PMID 8644759.